泽璟制药：ZG006有望重塑SCLC治疗面貌，公司在TCE赛道国内竞争优势显著
泽璟制药(688266) 信达证券·2024-09-13 21:03| --- | --- | --- | |----------------------------------------------------------------------------------------------------------|------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------ ...